T1	Participants 56 105	in melanoma patients with high serum MMP-8 levels
T2	Participants 389 397	melanoma
T3	Participants 418 488	from 460 patients with stage IIB-IIIC melanoma were analyzed for MMP-8
T4	Participants 845 886	months in patients with high MMP-8 levels
T5	Participants 1024 1061	survival for patients with high MMP-8
